RADX
Radiopharm Theranostics Ltd
$4.33
-0.04 (-0.92%)
At close · Jul 13
Market Cap
$33.90M
Shares
7,883,165
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.33
Open$4.26
Day$4.25–4.35
52W$3.62–16.25
Avg vol 30d21K
Short int63K · 0.8% float · 2.6d
Short vol84%
DataDec 2024–Jul 2026
Up next
FQ1-27 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 17.2 · elevated
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−12%
below
Price vs 50-day avg
−1%
below
RSI (14)
50
neutral
MACD trend
Positive
52-week position
6%
near low
Momentum
relative strength
1-month return
−1%
trailing
6-month return
−16%
trailing
YTD return
−17%
this year
Relative strength
−24%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow
Distributing
-36% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.79% of float · ▲ +45.2% MoM · 2.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
7 holders — mid 1-yr range
Squeeze score
58
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
172%
annualized · 1-yr
Max drawdown
−62%
past year
ATR
5.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−12%
Bearish
Price vs 50-day avg
−1%
Neutral
RSI (14)
50
Neutral
MACD trend
Positive
Bullish
52-week position
6%
Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow
Distributing
-36% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.79% of float · ▲ +45.2% MoM · 2.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
7 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $4
Now $4 · 6%
52-wk high $16
vs 200-day avg -12%
vs 50-day avg -1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RADX
this stock
Radiopharm Theranostics Ltd
|
$33.90M | -17.0% | — | — | 0.8% |
|
ONC
BeOne Medicines Ltd.
|
$439.30B | +0.0% | +22179.2% | 894.0 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.89B | +5.9% | +46.2% | 28.5 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.52B | -14.0% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$54.76B | +4.2% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
7
- % held
- 650.9%
- Net QoQ
- -231.5K sh
- Top holder
- Stonepine Capital Managem…
Held
Float
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RADX | -0.5% | -1.4% | -15.8% | +3.3% | -17.1% |
| SPY | -0.3% | +1.6% | +8.3% | +0.3% | +9.9% |
| vs SPY | -0.2% | -2.9% | -24.1% | +3.0% | -26.9% |